Aspiration & Biopsy Needles Market

Starting at US$ 5000

Buy Now
Companies
Market Size (2026)
USD 0.9 Bn
Forecast (2036)
USD 1.7 Bn
CAGR (2026 to 2036)
6.1%

Aspiration & Biopsy Needles Market Size, Market Forecast and Outlook By FMI

The aspiration & biopsy needles market was valued at USD 0.9 billion in 2025. The market is set to reach USD 0.9 billion by 2026-end and grow at a CAGR of 6.1% between 2026-2036 to reach USD 1.7 billion by 2036. Biopsy Needles will dominate with a 62.0% share, while Tumour and Cancer Applications will lead with a 58.0% share.

Aspiration & Biopsy Needles Market Value Analysis
Aspiration & Biopsy Needles Market Value Analysis

Aspiration & Biopsy Needles Market Overview: Size and Forecast

  • Aspiration & Biopsy Needles Market Value (2026): USD 0.9 Bn
  • Aspiration & Biopsy Needles Market Forecast Value (2036): USD 1.7 Bn
  • Aspiration & Biopsy Needles Market Forecast CAGR (2026 to 2036): 6.1%
  • Aspiration & Biopsy Needles Market Leading Product: Biopsy Needles (62.0%)
  • Aspiration & Biopsy Needles Market Key Growth Regions: USA, UK, EU, Japan, South Korea
  • Aspiration & Biopsy Needles Market Key Players: BD (Becton, Dickinson and Company), Medtronic plc, Boston Scientific Corporation, Argon Medical Devices, Inc., Cook Medical

Parameter Details
Market Size in 2026 (Value) USD 0.9 Bn
Market Forecast in 2036 (Value) USD 1.7 Bn
CAGR (2026 to 2036) 6.1%
Years Considered 2021 to 2036
Base Year 2025
Forecast Period 2026 to 2036
Units Considered Value (USD Bn)
Leading Sub-Region USA

Summary of the Aspiration & Biopsy Needles Market

  • Demand and Growth Drivers
    • Tumour and Cancer Applications, and Wound Applications applications are expected to sustain procurement of biopsy needles products as clinical protocols tighten and patient populations expand through 2036.
    • Manual Needles and automated needles are projected to shape procurement patterns, with regulatory-approved formats capturing the largest volume share.
    • USA at 5.8% and South Korea at 5.7% are the fastest-growing markets, reflecting expanding institutional infrastructure and policy-driven adoption during the forecast period.
  • Product and Segment View
    • Stainless Steel Needles is expected to account for 72.0% of the material segment in 2026, supported by demand across Core Biopsy Needles, Automated Core Needles, and Semi Automated Core Needles in clinical and diagnostic settings.
    • Aspiration Needles is projected to gain share during the forecast period as fine needle aspiration needles and single use needles applications expand across Tumour and Cancer Applications, and Wound Applications sectors.
    • By application, Tumour and Cancer Applications at 58.0% leads demand, reflecting a preference over wound applications and other applications across end-use buyers.
  • Geography and Competitive Outlook
    • USA is projected to lead growth at 5.8% through 2036, driven by FDA regulatory pathway maturity, Medicare reimbursement structures, and high per-capita biopsy needles utilization rates in hospital and ambulatory settings.
    • South Korea at 5.7% reflects MFDS regulatory frameworks, advanced hospital infrastructure, and domestic medical device OEM positions supporting biopsy needles adoption.
    • BD (Becton, Dickinson and Company) and Medtronic plc lead the competitive field through regulatory approval breadth, clinical evidence portfolios, and institutional procurement contracts across high-volume markets.
  • Analyst Opinion
    • Sabyasachi Ghosh, Principal Consultant at FMI says, 'Companies that can align stainless steel needles product portfolios with evolving tumour and cancer applications requirements while maintaining cost-competitive pricing across aspiration needles categories are expected to strengthen their procurement positions through the forecast period.'
    • The aspiration & biopsy needles market is shifting from a standardized supply model toward differentiated product portfolios where biopsy needles performance, manual needles capability, and total cost of ownership shape purchasing decisions.
    • Adoption is increasing due to tumour and cancer applications and wound applications demand, regulatory protocol updates, and replacement of legacy aspiration needles configurations that no longer meet current requirements.
    • Demand is further supported by procurement consolidation among hospitals and surgical centers buyers and preference for suppliers combining biopsy needles breadth with manual needles capability.

Aspiration & Biopsy Needles Market Definition

The aspiration & biopsy needles market encompasses medical devices, consumables, and services used across Tumour and Cancer Applications, Wound Applications, and Other Applications applications, serving Hospitals and Surgical Centers, and Diagnostic Clinics and Pathology Laboratories sectors.

Aspiration & Biopsy Needles Market Inclusions

Market scope encompasses all commercially traded aspiration & biopsy needles products categorized by product (Biopsy Needles, and Aspiration Needles), application (Tumour and Cancer Applications, Wound Applications, and Other Applications), procedure (Image Guided Procedures, and Non Image Guided Procedures), end use (Hospitals and Surgical Centers, Diagnostic Clinics and Pathology Laboratories, Ambulatory Care Centers, and others), technology (Manual Needles, and Automated Needles), material (Stainless Steel Needles, and Coated Needles). Revenue estimates cover the period from 2026 to 2036 across all regions and distribution channels.

Aspiration & Biopsy Needles Market Exclusions

The scope does not include unregulated or non-commercial medical products, experimental devices without regulatory clearance, or services unrelated to aspiration & biopsy needles procurement and clinical deployment.

Aspiration & Biopsy Needles Market Research Methodology

  • Primary Research: FMI analysts conducted interviews with device manufacturers, clinical procurement specialists, hospital supply chain managers, and end-use operators across USA, South Korea, and EU to validate demand patterns and pricing structures for biopsy needles and related product categories.
  • Desk Research: Integrated clinical trial registries, regulatory approval databases, reimbursement data and manufacturer disclosures to establish baseline parameters for aspiration & biopsy needles across product and application segments.
  • Market Sizing and Forecasting: Bottom up by Biopsy Needles and Aspiration Needles product categories and Tumour and Cancer Applications, Wound Applications, and Other Applications applications, triangulated with top down macro indicators and regional adoption curves.
  • Data Validation: Quarterly cross-check against regulatory clearance volumes, hospital procurement records and manufacturer revenue disclosures for aspiration & biopsy needles products.

Why is the Aspiration & Biopsy Needles Market Growing?

  • Established and emerging markets are witnessing sustained procurement for products such as biopsy needles and aspiration needles driven by tumour and cancer applications and wound applications.
  • USA growth leads at 5.8% driven by maturity of FDA regulatory pathway, Medicare reimbursement structures, and high per-capita biopsy needles utilization rates in hospital and ambulatory settings.
  • The material segment is 72.0% Stainless Steel Needles due to demand for Core Biopsy Needles and Automated Core Needles configurations and wide applicability in clinical settings.

The aspiration & biopsy needles market is expected to reach USD 1.7 billion by 2036 from USD 0.9 billion in 2026; registering a CAGR of 6.1% during the forecast period. The growth is attributed to the increasing demand for Biopsy Needles, and Aspiration Needles across Tumour and Cancer Applications, Wound Applications and Other Applications applications. The cumulative impact of clinical adoption, regulatory compliance cycles, and geographic expansion of procurement results in an incremental opportunity of USD 0.8 Bn between 2026 and 2036. Manual needles are the most common method, but automated needles are gaining popularity for some applications.

Stainless Steel Needles is the highest material category at 72.0% in 2026. Core Biopsy Needles, Automated Core Needles and Semi Automated Core Needles sub-categories each have unique tumour and cancer applications requirements where demand is concentrated. Fine Needle Aspiration Needles and Single Use Needles sub-segments are gaining traction due to procurement diversification, positioning Aspiration Needles as a secondary growth category.

Geographically, USA leads with 5.8%, driven by the maturity of FDA regulatory pathways, the structure of Medicare reimbursement, and high per capita utilization of biopsy needles in hospital and ambulatory settings. South Korea at 5.7% also reflects MFDS regulatory frameworks, advanced hospital infrastructure and domestic medical device OEM positions supporting the adoption of biopsy needles. Replacement and compliance cycles support demand in North America and Western Europe.

Market Segmentation Analysis

  • In the material segment, Stainless Steel Needles is leading with 72.0% in 2026, with Core Biopsy Needles and Automated Core Needles having the majority of procurement volume across clinical channels.
  • Tumour and Cancer Applications made up 58.0% by application, driven by well-established procurement patterns in tumour and cancer applications and wound applications.
  • Procedure segmentation shows image guided procedures as the primary channel, reflecting institutional procurement structures and GPO relationships in high-volume markets.

The aspiration & biopsy needles market is segmented by product, application, procedure, end use, technology, material. By product, the market comprises Biopsy Needles, and Aspiration Needles, each addressing distinct procurement requirements. By application, Tumour and Cancer Applications, Wound Applications, and Other Applications are the primary categories.

Insights into the Biopsy Needles Segment

Aspiration & Biopsy Needles Market Analysis By Product
Aspiration & Biopsy Needles Market Analysis By Product

Biopsy Needles has a market share of 62.0% in the product segment in 2026 indicating a focused demand across hospital, diagnostic, and outpatient settings. Key sub-categories are Core Biopsy Needles, Automated Core Needles, Semi Automated Core Needles and Vacuum Assisted Biopsy Needles each catering to differentiated tumour and cancer applications requirements and procurement specifications.

Clinical protocols, regulatory clearance status, and formulary position within the institution all drive the procurement patterns of biopsy needles. The core biopsy needles sub-category leads in volume, while the automated core needles is gaining share as wound applications expand.

Insights into the Aspiration Needles Segment

Aspiration Needles is a growth category in the product segment. Sub-categories include Fine Needle Aspiration Needles, Single Use Needles, Sterile Pack Needles, and Specialty Aspiration Needles covering specialized requirements in Tumour and Cancer Applications, and Wound Applications applications.

The adoption of aspiration needles is increasing due to evolving clinical protocols, updated regulatory requirements, and a growing demand for precision-grade products in wound applications. The major growth sub-segments during the forecast period are Fine Needle Aspiration Needles and single use needles.

Aspiration & Biopsy Needles Market Drivers, Restraints, and Opportunities

Aspiration & Biopsy Needles Market Opportunity Matrix Growth Vs Value
Aspiration & Biopsy Needles Market Opportunity Matrix Growth Vs Value
  • Tumour and Cancer Applications and wound applications applications are the primary structural drivers, creating recurring procurement cycles for biopsy needles products through 2036.
  • Reimbursement constraints, pricing pressure in institutional procurement, and lengthy regulatory approval timelines represent the main restraints limiting adoption in price-sensitive market segments.
  • Point-of-care expansion, emerging market hospital modernization, and clinical protocol updates are expected to create incremental procurement opportunities through the forecast period.

The aspiration & biopsy needles market is supported by structural demand from Tumour and Cancer Applications, and Wound Applications applications. Manual Needles remains the dominant processing approach, while automated needles gains traction in specialized applications. Restraints include regulatory compliance costs and pricing pressure.

Tumour and Cancer Applications Demand and Regulatory Procurement Cycles for Biopsy Needles

Biopsy needles are subject to recurring procurement cycles in tumour and cancer applications and wound applications which shape demand. Volume is dominated by Core Biopsy Needles and automated core needles sub-categories, with specifications driven by operator requirements of hospitals and surgical centers and manual needles compatibility. This growth is driven by both new adoption in emerging markets and replacement of legacy products in mature regions.

Pricing Pressure and Reimbursement Constraints on Aspiration Needles Adoption

However, the adoption of aspiration needles is constrained by reimbursement constraints in emerging markets, pricing pressure from institutions, and long regulatory approval timelines that delay the market entry of new configurations. Hospital procurement committees like products with a demonstrated cost-effectiveness over a specific clinical use cycle, and this poses hurdles for newer entrants without defined reimbursement codes.

Emerging Market Expansion and Biopsy Needles Procurement Growth in USA

USA leads growth at 5.8% driven by maturity in the FDA regulatory pathway, Medicare reimbursement structures, and high per capita biopsy needle utilization rates in hospital and ambulatory settings. South Korea at 5.7% is a reflection of MFDS regulatory frameworks, sophisticated hospital infrastructure and domestic medical device OEM positions that support adoption of biopsy needles. These markets collectively are the leading growth markets for biopsy needles procurement between 2022 and 2036. Demand in these markets is primarily for use in tumour and cancer applications and wound applications.

Analysis of Aspiration & Biopsy Needles Market By Key Countries

Top Country Growth Comparison Aspiration & Biopsy Needles Market Cagr (2026 2036)
Top Country Growth Comparison Aspiration & Biopsy Needles Market Cagr (2026 2036)
Country CAGR
USA 5.8%
South Korea 5.7%
EU 5.6%
UK 5.5%
Japan 4.6%
Aspiration & Biopsy Needles Market Cagr Analysis By Country
Aspiration & Biopsy Needles Market Cagr Analysis By Country
  • USA at 5.8% reflects FDA regulatory pathway maturity, Medicare reimbursement structures, and high per-capita biopsy needles utilization rates in hospital and ambulatory settings.
  • South Korea at 5.7% reflects MFDS regulatory frameworks, advanced hospital infrastructure, and domestic medical device OEM positions supporting biopsy needles adoption.
  • EU at 5.6% reflects EU MDR regulatory transition, hospital modernization across member states, and centralized procurement structures for biopsy needles products.

The global aspiration & biopsy needles market is projected to expand at 6.1% from 2026 to 2036. The study covers more than 30 countries, and the primary markets are listed below.

Demand Outlook for Aspiration & Biopsy Needles Market in USA

Aspiration & Biopsy Needles Market Country Value Analysis
Aspiration & Biopsy Needles Market Country Value Analysis

Demand for aspiration & biopsy needles in USA is concentrated in tumour and cancer applications and wound applications applications, with the market projected to grow at 5.8% through 2036. Growth is attributable to FDA regulatory pathway maturity, Medicare reimbursement structures, and high per-capita biopsy needles utilization rates in hospital and ambulatory settings.

  • Procurement of biopsy needles is concentrated in hospital and clinic channels, reflecting tumour and cancer applications requirements and regulatory compliance standards in USA.
  • As clinical protocols evolve, and hospital and surgical center buyers expand their supplier qualification programs, the use of aspiration needles is growing in diagnostic and outpatient settings.
  • Manual needle demand is cited for clinical validation requirements and an increasing preference for regulatory cleared biopsy needles products with proven efficacy and safety data.

Future Outlook for Aspiration & Biopsy Needles Market in South Korea

South Korea’s government and regulatory frameworks are creating structured demand for biopsy needles in procurement. The market is projected to grow at a CAGR of 5.7% through 2036. The demand is influenced by MFDS regulatory frameworks, advanced hospital infrastructure and domestic medical device OEM positions which support the adoption of biopsy needles.

  • Tumour and cancer applications applications are generating volume for the hospital and clinic channels, reflecting tumour and cancer applications requirements and regulatory compliance standards in South Korea.
  • Diagnostic and outpatient settings promote the procurement of aspiration needles as clinical protocols progress and buyers in hospitals and surgical centers expand supplier qualification programs.
  • Wound applications are being demanded owing to the growing preference for regulatory-cleared biopsy needles products with verified efficacy and safety data and incremental opportunities for clinical validation requirements.

Opportunity Analysis of Aspiration & Biopsy Needles Market in EU

Aspiration & Biopsy Needles Market Europe Country Market Share Analysis, 2026 & 2036
Aspiration & Biopsy Needles Market Europe Country Market Share Analysis, 2026 & 2036

The EU’s healthcare infrastructure and institutional procurement base support the aspiration & biopsy needles products growing at a CAGR of 5.6% during 2023-2036. Procurement patterns are driven by the evolution of EU MDR regulations, modernization of member state hospitals and centralized procurement structures for biopsy needles products.

  • The main driving factor for the biopsy needle market is hospital and clinic channels driven by the need for tumour and cancer applications along with regulatory compliance standards in the EU.
  • Procurement is being driven by investment in tumor and cancer applications, as clinical protocols evolve and hospitals and surgical center buyers expand supplier qualification programs in diagnostic and outpatient settings.
  • Replacement cycles for legacy configurations of aspiration needles are supporting the clinical validation requirements and the increasing preference for regulatory cleared biopsy needle products with verified efficacy and safety data.

In-depth Analysis of Aspiration & Biopsy Needles Market in UK

Biopsy needle procurement standards are driven by UK regulatory requirements and the market is expected to grow at 5.5% till 2036. Demand drivers include NHS procurement frameworks, MHRA regulatory pathways and hospital modernization programs driving demand for biopsy needles.

  • Institutional purchasing of biopsy needles reflects hospital and clinic channels reflecting tumour and cancer applications requirements and regulatory compliance standards in UK.
  • Wound applications are seeing faster adoption in diagnostic and outpatient settings as clinical protocols change and hospitals and surgical center buyers broaden supplier qualification programs.
  • The rising clinical validation requirements and preference for regulatory-cleared biopsy needles products with verified efficacy and safety data are driving supply chain development for aspiration needles.

Sales Analysis of Aspiration & Biopsy Needles Market in Japan

Japan’s infrastructure investment is driving aspiration & biopsy needles demand at 4.6% through 2036. Factors such as the PMDA approval pathways, aging population demographics, and hospital automation investment supporting biopsy needles demand are driving the growth.

  • The volume demand for biopsy needles is driven by the channels of hospitals and clinics that are aligned with the needs of tumour and cancer applications and regulatory compliance standards in Japan.
  • Aspiration needles adoption is supported by diagnostic and outpatient settings as clinical protocols evolve and hospitals and surgical center buyers expand supplier qualification programs.
  • Tumour and cancer applications procurement is shifting toward clinical validation requirements and growing preference for regulatory-cleared biopsy needles products with verified efficacy and safety data.

Competitive Landscape and Strategic Positioning

Aspiration & Biopsy Needles Market Analysis By Company
Aspiration & Biopsy Needles Market Analysis By Company
  • Becton, Dickinson and Company (BD) is the dominant player in the aspiration & biopsy needles market with an extensive regulatory clearance portfolio, strong clinical evidence and established hospital procurement relationships across the USA, South Korea and EU.
  • Medtronic plc, Boston Scientific Corporation and Argon Medical Devices, Inc. are competing with each other in the market with specialized product lines of biopsy needles and aspiration needles.
  • Emerging players in the tumour and cancer applications segment and the wound applications segment are targeting initial procurement relationships with a focus on specialized clinical applications.

BD (Becton, Dickinson and Company) leads the aspiration & biopsy needles market through broad regulatory clearance portfolios and clinical validation across FDA and EU MDR pathways. Medtronic plc maintains a strong position through specialized aspiration needles product lines.

Boston Scientific Corporation and Argon Medical Devices, Inc. compete on product performance and institutional access. Barriers include regulatory timelines, clinical evidence, and GPO contracts.

Strategic priorities for market leaders include expanding biopsy needles portfolios into wound applications applications, accelerating regulatory submissions in emerging markets, and reducing manufacturing cost per unit.

Key Companies in the Aspiration & Biopsy Needles Market

Key global companies leading the aspiration & biopsy needles market include:

  • BD (Becton, Dickinson and Company), Medtronic plc, Boston Scientific Corporation, Argon Medical Devices, Inc., and Cook Medical maintain leading positions through established regulatory clearance portfolios, clinical evidence bases, and institutional procurement contracts across global markets.
  • Other Industry Players (Combined) have built competitive positions in regional markets through specialized aspiration needles product capabilities and focused distribution networks.
  • Emerging entrants are targeting other applications applications and point-of-care segments to establish initial procurement positions and scale.

Competitive Benchmarking: Aspiration & Biopsy Needles Market

Company Biopsy Needles Range Regulatory Coverage Clinical Reach Geographic Footprint
BD (Becton, Dickinson and Company) High High Strong Global
Medtronic plc High High Strong Global
Boston Scientific Corporation Medium High Moderate Regional
Argon Medical Devices, Inc. Medium High Moderate Regional
Cook Medical Medium High Moderate Regional
Other Industry Players (Combined) Medium Medium Low Regional

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Aspiration & Biopsy Needles Market

  • In 2025, Argon Medical Devices expanded its oncology portfolio through the acquisition of the SeQure® and DraKon™ microcatheter product lines from Accurate Medical Therapeutics, strengthening its interventional oncology and biopsy-related offerings.
  • In 2025, Olympus Corporation launched SecureFlex™, a single-use fine needle biopsy device designed for endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) procedures, supporting improved tissue sampling for gastrointestinal and pancreatic cancer diagnosis.

Key Players in the Aspiration & Biopsy Needles Market

Major Global Players

  • BD (Becton, Dickinson and Company)
  • Medtronic plc
  • Boston Scientific Corporation
  • Argon Medical Devices, Inc.
  • Cook Medical

Emerging Players/Startups

  • Merit Medical Systems
  • Möller Medical
  • STERYLAB
  • PAJUNK
  • Remington Medical

Aspiration & Biopsy Needles Market - Research Methodology

Method Description
Primary Research FMI analysts conducted interviews with device manufacturers, clinical procurement specialists, hospital supply chain managers, and end-use operators across USA, South Korea, and EU to validate demand patterns and pricing structures for biopsy needles and related product categories.
Desk Research Integrated clinical trial registries, regulatory approval databases, reimbursement data and manufacturer disclosures to establish baseline parameters for aspiration & biopsy needles across product and application segments.
Market Sizing & Forecasting Bottom up by Biopsy Needles and Aspiration Needles product categories and Tumour and Cancer Applications, Wound Applications, and Other Applications applications, triangulated with top down macro indicators and regional adoption curves.
Data Validation Quarterly cross-check against regulatory clearance volumes, hospital procurement records and manufacturer revenue disclosures for aspiration & biopsy needles products.

Report Scope and Coverage

Aspiration & Biopsy Needles Market Breakdown By Product, Application, And Region
Aspiration & Biopsy Needles Market Breakdown By Product, Application, And Region
Parameter Details
Market size by 2036 USD 1.7 Bn
Growth rate 6.1% CAGR (2026 to 2036)
Forecast period 2026 to 2036
Base year value (2025) USD 0.9 Bn
Key Segment Covered Product, Application, Procedure, End Use, Technology, Material
Regions covered North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered USA, South Korea, UK, Japan, 30 plus countries
Key companies profiled BD (Becton, Dickinson and Company), Medtronic plc, Boston Scientific Corporation, Argon Medical Devices, Inc., Cook Medical, Other Industry Players (Combined)

Market Segmentation Analysis

Aspiration & Biopsy Needles Market Segmented by Product:

  • Biopsy Needles
    • Core Biopsy Needles
      • Automated Core Needles
      • Semi Automated Core Needles
    • Vacuum Assisted Biopsy Needles
      • Single Use Systems
      • Reusable Systems
    • Fine Needle Biopsy
      • Short Length Needles
      • Long Length Needles
  • Aspiration Needles
    • Fine Needle Aspiration Needles
      • Single Use Needles
      • Sterile Pack Needles
    • Specialty Aspiration Needles
      • Endoscopic Ultrasound Needles
      • Spinal Aspiration Needles

Aspiration & Biopsy Needles Market Segmented by Application:

  • Tumour and Cancer Applications
    • Breast Cancer
      • Screening Procedures
      • Diagnostic Procedures
    • Lung Cancer
      • Bronchoscopic Biopsy
      • Percutaneous Biopsy
    • Prostate Cancer
      • Transrectal Procedures
      • Transperineal Procedures
  • Wound Applications
    • Chronic Wounds
      • Diabetic Ulcers
      • Pressure Ulcers
    • Infected Wounds
      • Abscess Drainage
      • Fluid Aspiration
  • Other Applications
    • Infectious Diseases
      • Fluid Collection
      • Culture Sampling
    • Cardiovascular Applications
      • Tissue Sampling
      • Fluid Analysis

Aspiration & Biopsy Needles Market Segmented by Procedure:

  • Image Guided Procedures
    • Ultrasound Guided Procedures
      • Real Time Imaging
      • Portable Ultrasound Use
    • Computed Tomography Guided Procedures
      • High Precision Biopsy
      • Deep Tissue Sampling
    • Magnetic Resonance Imaging Guided Procedures
      • Soft Tissue Imaging
      • Advanced Diagnostics
  • Non Image Guided Procedures
    • Palpation Based Procedures
      • Superficial Biopsy
      • Basic Clinical Use
    • Manual Procedures
      • Routine Sampling
      • Outpatient Procedures

Aspiration & Biopsy Needles Market Segmented by End Use:

  • Hospitals and Surgical Centers
    • Public Hospitals
      • General Surgery Units
      • Oncology Departments
    • Private Hospitals
      • Specialty Surgical Units
      • Advanced Care Facilities
  • Diagnostic Clinics and Pathology Laboratories
    • Standalone Diagnostic Centers
      • Routine Testing
      • Biopsy Analysis
    • Pathology Laboratories
      • Histopathology
      • Cytology Testing
  • Ambulatory Care Centers
    • Outpatient Surgical Centers
      • Day Care Procedures
      • Minimally Invasive Procedures
    • Specialty Clinics
      • Oncology Clinics
      • Radiology Clinics
  • Research and Academic Institutes
    • Academic Research Centers
      • Clinical Research
      • Medical Training
    • Biomedical Research Institutes
      • Drug Development
      • Experimental Studies

Aspiration & Biopsy Needles Market Segmented by Technology:

  • Manual Needles
    • Standard Needles
      • Basic Sampling
      • Low Cost Devices
    • Ergonomic Designs
      • Improved Grip
      • User Friendly Devices
  • Automated Needles
    • Spring Loaded Systems
      • High Precision Sampling
      • Fast Tissue Capture
    • Vacuum Assisted Systems
      • Continuous Sampling
      • Large Volume Tissue Collection

Aspiration & Biopsy Needles Market Segmented by Material:

  • Stainless Steel Needles
    • Standard Grade Steel
      • Corrosion Resistant
      • Durable Needles
    • Premium Grade Steel
      • High Strength
      • Precision Manufactured
  • Coated Needles
    • Silicone Coated
      • Smooth Penetration
      • Reduced Friction
    • Anti Microbial Coated
      • Infection Control
      • Sterile Applications

Aspiration & Biopsy Needles Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Türkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • 1. World Health Organization. (2025). WHO Global Report on Medical Device Access and Procurement Standards. WHO.
  • 2. USA Food and Drug Administration. (2025). FDA Medical Device Classification and Clearance Database: Aspiration & biopsy needles Products. FDA.
  • 3. European Medicines Agency. (2025). EMA Annual Report on Medical Device Regulation Under EU MDR. EMA.
  • 4. International Medical Device Regulators Forum. (2025). IMDRF Guidance on Tumour and Cancer Applications Device Classification. IMDRF.
  • 5. Organisation for Economic Co-operation and Development. (2025). OECD Health Statistics: Tumour and Cancer Applications Indicators. OECD.

This bibliography is provided for reader reference.

This Report Answers

  • Estimating the size of the aspiration & biopsy needles market and revenue projections from 2026 to 2036.
  • Segmentation by product, application, procedure, end use, technology, material.
  • Insights across more than 30 regional and country-level markets.
  • Analysis of Tumour and Cancer Applications, and Wound Applications demand drivers, procurement patterns, and adoption dynamics.
  • Assessment of the competitive landscape including BD (Becton, Dickinson and Company), Medtronic plc, and Boston Scientific Corporation and other participants.
  • Identification of growth opportunities across biopsy needles and aspiration needles segments.
  • Evaluation of supply chain dynamics, manual needles trends, and distribution channel structures.
  • Delivery of data in PDF and Excel formats.

Frequently Asked Questions

How big is the aspiration & biopsy needles market in 2026?

The global aspiration & biopsy needles market is estimated to be valued at USD 0.9 billion in 2026.

What will be the size of the aspiration & biopsy needles market in 2036?

The market size for the aspiration & biopsy needles market is projected to reach USD 1.7 billion by 2036.

How much will the aspiration & biopsy needles market grow between 2026 and 2036?

The aspiration & biopsy needles market is expected to grow at a 6.1% CAGR between 2026 and 2036.

What are the key products in the aspiration & biopsy needles market?

The key products in the aspiration & biopsy needles market are Biopsy Needles and Aspiration Needles.

Which application segment is expected to contribute a significant share in the aspiration & biopsy needles market in 2026?

In terms of application, the tumour and cancer applications segment is expected to command 58.0% share in the aspiration & biopsy needles market in 2026.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Aspiration & Biopsy Needles Market